SlideShare a Scribd company logo
Irish Pharmaceutical
Healthcare Association (IPHA)
Annual Meeting
Barry O’Leary
November 25th 2010
Current Impact of FDI
gh
KEY FDI IMPACTS ON THE IRISH
ECONOMY
- €110 BN Exports
- 240,000 Jobs in Total
- 55% of Corporation Tax
- €19 BN Expenditure
- €7 BN Payroll
- 73% of Business RD&I expenditure
WORLD LEADERS CHOOSE IRELAND
- 8 of the top 10 in ICT
- 8 of the top 10 in Pharmaceuticals
- 15 of the top 25 in Medical Devices
- More than 50% of the world’s leading
Financial Services firms
• Global Services
• High-end Manufacturing
• Research, Development & Innovation
Business Model Focus
Sectors
• Life Sciences - Pharma/Biopharma &
- Medical Devices
• Information & Communications Technology
• Financial Services
• Content Industry, Consumer & Business
Services
• Diversified Industries and Engineering
• CleanTech
IDA Focus
FDI 2010 – Recent Wins
Existing Clients
FDI Recent Wins – New Clients
Ireland – major Life Sciences Hub
Biopharma Med Tech
Healthcare
Services
• 8 0f the top 10 Pharma
• 8 of top 10 and 15 of top 25
Medical Technologies
• 44,000 jobs
• Exports €51 Bn p.a.
• Numerous sub-suppiier and
service providers
Recent Lifesciences FDI
Investments
Investing €220m in a new fill finish vaccines facility (170 jobs)
Carlow. EMEA Service Centre in Dublin (150 Jobs).
EMEA Shared Services for 100 people, Cork.
Biologics, €400m investment.
Investing over €160m in R&D in Galway, Cork and Clonmel
Global manufacturing and development, 204 people, Dundalk
100 person manufacturing expansion in Co. Galway
250 person manufacturing expansion in Ballina
€30m investment in bio-analytical / chemistry services, 250 Jobs in Athlone
Expansion of €130m and 170 new jobs
European Shared Services Centre in Cork - 30 jobs
European Services Centre in Dublin, creating more than 200 job.
€50 million new manufacturing investment, creating 250 jobs in Clare
Global Lifesciences Industry
Drivers/Challenges
Pharma
• Patent cliff – increased
generics
• Pipeline Challenge
• Restructuring to
accommodate new reality
– M&A, cost reduction
• Increasing Regulatory
hurdles and costs
• US Healthcare reform –
biosimilars pathway
• Biologics
• Rise of Asia
• Ageing population
• Healthcare reform tax
• 510K regulatory pathway
changes USA
• Convergence – clear
coupling of devices and
tech.
• Asian market growing
strongly
9
Ageing population
20%+ of population will be over 65 in
developed markets by 2025
Emerging markets
Pharma market expected to double by 2015
Unmet needs
Oncology, immunology, antiviral HIV, stroke,
Alzheimer's, obesity, thrombosis, HCV
New technologies
e.g., Predictive technologies, such as
biomarkers, in silico models
Increasing
demand
Demand for healthcare to continue to grow
Broader
offer
1. Source : IMS Market prognosis
Copyright©2010byTheBostonConsultingGroup,Inc.Allrightsreserved.
Evolution of Pharma Bio
• Single Platform Technology
• API manufacturing
• Q&A labs
• Sophisticated
manufacturing
• Liquids
• Tabletting
• Creams
• Patches
• Molecular
diagnostics
• Reference
Global Sites
• Biopharma
• Shared
services -
Supply chain,
Regulatory,
Finance
• Commodity
medicines
• Self-Dx, Self
Treat
• Nutraceuticals
• Convergent
technologies
• Connected
Health
• Personalised
Medicine
• Combination
medical
products
• Medical Services
1980s 1990s 2000s 2020
11
Horizon 2020 - Ongoing Evolution of Pharma Bio
2010-2015- Capturing and Delivering marketplace opportunites
• Integrating disease with lifestyle management
• Leveraging expertise in nutraceuticals, point of care assays
• Advancing molecular diagnostics and targetted therapies
• Utilising genetic testing & biomarkers in advanced clinical trials
• Developing convergent medical products
• Rise of bioinfomatics, population health strategies
Now - Building and Developing the sector
• Winning new biopharma investments
• Leveraging NiBRT to advance Biopharma Industry
• Enhancing Ireland’s small molecule Value Proposition
• Support vaccine development, generic reformulation, improved drug delivery
• Expanding mandates of top 30 companies “start earlier-finish later”
• Supporting new starts in packaging, tabletting, labelling, supply chain
• Expanding footprints into shared services, commercialisation, clinical trials
12
Horizon 2020 - Ongoing Evolution of Pharma Bio
2020 Foresight
• Convergent medical management – drug & dynamic device
• Regenerative Health platforms in ageing, organ, joint replacement
• Connected Health platforms integrating e-health
• Cancer vaccines, targeted personal therapies
• Advancing silver care, aged care, focus on mental wellness
• Tailored health insurance per decade of life
• Development of “polypill”
• Integrated digital medical record and decision support
• Remote monitoring and treatment at home
• New bioactive materials and molecules from marine ecosystem
Ireland : A Proven Location for
Lifesciences Service Activities
Initiatives to protect and grow Industry
• Transformation –
– Technology uplift,
– Skills uplift
– Process development
– Product Development
– Energy Efficiency
– Operational excellence
• Strategic Sites and CMO
• NIBRT for Bio
• National Commercialisation centre for medical devices
• National competence centre for small molecule production
• International healthcare services centre
• Healthcare Innovation hub with HSE
• Research and Development Agenda
• TV Ads
• Live TV Interviews
• Online Media
• Print Media
• Airport Posters
• Press Interviews
• Web Optimisation
Integrated Communications Campaign
Professor Luke O’Neill – Trinity College Dublin
IDA TV Ad – 30 Secs
Thank You

More Related Content

What's hot

Best Practices in the Field of Serialization and Safe Supply Chain
Best Practices in the Field of Serialization and Safe Supply Chain Best Practices in the Field of Serialization and Safe Supply Chain
Best Practices in the Field of Serialization and Safe Supply Chain
László Árvai
 
Lessons learned from retail logistics in the Netherlands
Lessons learned from retail logistics in the NetherlandsLessons learned from retail logistics in the Netherlands
Lessons learned from retail logistics in the Netherlands
Walther Ploos van Amstel
 
London global transparency pc15105 brochure
London global transparency pc15105 brochureLondon global transparency pc15105 brochure
London global transparency pc15105 brochure
Market iT
 
Disinfectant Listing Scheme - APEG
Disinfectant Listing Scheme - APEGDisinfectant Listing Scheme - APEG
Addressing the challenge of the new European Union Medical Device Regulation
Addressing the challenge of the new European Union Medical Device RegulationAddressing the challenge of the new European Union Medical Device Regulation
Addressing the challenge of the new European Union Medical Device Regulation
EY Belgium
 
Overview of Common Technical Barriers to Trade
Overview of Common Technical Barriers to Trade Overview of Common Technical Barriers to Trade
Overview of Common Technical Barriers to Trade
Asian Food Regulation Information Service
 
Portugal: the right place to invest and build partnerships in Health | Health...
Portugal: the right place to invest and build partnerships in Health | Health...Portugal: the right place to invest and build partnerships in Health | Health...
Portugal: the right place to invest and build partnerships in Health | Health...
Luís Soares
 
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
Association of the British Pharmaceutical Industry (ABPI)
 
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceΜάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Starttech Ventures
 
UNITAID approach to working in markets to improve public health
UNITAID approach to working in markets to improve public healthUNITAID approach to working in markets to improve public health
UNITAID approach to working in markets to improve public health
UNITAID
 
Aegate Symposium Frankfurt June 2015 - Jan saevels
Aegate Symposium Frankfurt June 2015 - Jan saevelsAegate Symposium Frankfurt June 2015 - Jan saevels
Aegate Symposium Frankfurt June 2015 - Jan saevels
Aegate
 
Sanitary and phytosanitary measures
Sanitary and phytosanitary measuresSanitary and phytosanitary measures
Sanitary and phytosanitary measures
babasahebkumbhar
 
SMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceSMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conference
Dale Butler
 
Rephine symposium 2018
Rephine symposium 2018 Rephine symposium 2018
Rephine symposium 2018
Alex Aves
 
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
Association of the British Pharmaceutical Industry (ABPI)
 
Aegate Symposium Frankfurt June 2015 - Graham commercial publish
Aegate Symposium Frankfurt June 2015 - Graham commercial publishAegate Symposium Frankfurt June 2015 - Graham commercial publish
Aegate Symposium Frankfurt June 2015 - Graham commercial publish
Aegate
 
Chapter 3: Putting patients first
Chapter 3: Putting patients firstChapter 3: Putting patients first

What's hot (17)

Best Practices in the Field of Serialization and Safe Supply Chain
Best Practices in the Field of Serialization and Safe Supply Chain Best Practices in the Field of Serialization and Safe Supply Chain
Best Practices in the Field of Serialization and Safe Supply Chain
 
Lessons learned from retail logistics in the Netherlands
Lessons learned from retail logistics in the NetherlandsLessons learned from retail logistics in the Netherlands
Lessons learned from retail logistics in the Netherlands
 
London global transparency pc15105 brochure
London global transparency pc15105 brochureLondon global transparency pc15105 brochure
London global transparency pc15105 brochure
 
Disinfectant Listing Scheme - APEG
Disinfectant Listing Scheme - APEGDisinfectant Listing Scheme - APEG
Disinfectant Listing Scheme - APEG
 
Addressing the challenge of the new European Union Medical Device Regulation
Addressing the challenge of the new European Union Medical Device RegulationAddressing the challenge of the new European Union Medical Device Regulation
Addressing the challenge of the new European Union Medical Device Regulation
 
Overview of Common Technical Barriers to Trade
Overview of Common Technical Barriers to Trade Overview of Common Technical Barriers to Trade
Overview of Common Technical Barriers to Trade
 
Portugal: the right place to invest and build partnerships in Health | Health...
Portugal: the right place to invest and build partnerships in Health | Health...Portugal: the right place to invest and build partnerships in Health | Health...
Portugal: the right place to invest and build partnerships in Health | Health...
 
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
 
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceΜάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
 
UNITAID approach to working in markets to improve public health
UNITAID approach to working in markets to improve public healthUNITAID approach to working in markets to improve public health
UNITAID approach to working in markets to improve public health
 
Aegate Symposium Frankfurt June 2015 - Jan saevels
Aegate Symposium Frankfurt June 2015 - Jan saevelsAegate Symposium Frankfurt June 2015 - Jan saevels
Aegate Symposium Frankfurt June 2015 - Jan saevels
 
Sanitary and phytosanitary measures
Sanitary and phytosanitary measuresSanitary and phytosanitary measures
Sanitary and phytosanitary measures
 
SMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceSMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conference
 
Rephine symposium 2018
Rephine symposium 2018 Rephine symposium 2018
Rephine symposium 2018
 
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
 
Aegate Symposium Frankfurt June 2015 - Graham commercial publish
Aegate Symposium Frankfurt June 2015 - Graham commercial publishAegate Symposium Frankfurt June 2015 - Graham commercial publish
Aegate Symposium Frankfurt June 2015 - Graham commercial publish
 
Chapter 3: Putting patients first
Chapter 3: Putting patients firstChapter 3: Putting patients first
Chapter 3: Putting patients first
 

Similar to The IDA Ireland strategy for the pharmaceutical industy in Ireland

Innovate UK - Chris Geary
Innovate UK - Chris GearyInnovate UK - Chris Geary
Innovate UK - Chris Geary
Sophie Johnson, PhD
 
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Mindtrek
 
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh
"Where Agri Meets Tech,  Driving Research to Market" Ultan O’Raghallaigh "Where Agri Meets Tech,  Driving Research to Market" Ultan O’Raghallaigh
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh
Asia Matters
 
The Cell Therapy Catapult: Keith Thompson CEO January 2013
The Cell Therapy Catapult: Keith Thompson CEO January 2013The Cell Therapy Catapult: Keith Thompson CEO January 2013
The Cell Therapy Catapult: Keith Thompson CEO January 2013
Cell and Gene Therapy Catapult
 
Presentation - Funding for Innovation in Life & Health Sciences
Presentation - Funding for Innovation in Life & Health SciencesPresentation - Funding for Innovation in Life & Health Sciences
Presentation - Funding for Innovation in Life & Health Sciences
Invest Northern Ireland
 
EIC slides april 23 20203.pptx
EIC slides april 23 20203.pptxEIC slides april 23 20203.pptx
EIC slides april 23 20203.pptx
FasikaMekete
 
Fra olje til helseteknologi
Fra olje til helseteknologiFra olje til helseteknologi
Fra olje til helseteknologi
nucleusas
 
Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)
TR3S PROJECT
 
TCIOceania15 WelfareTech - Towards Industrialisation
TCIOceania15 WelfareTech - Towards IndustrialisationTCIOceania15 WelfareTech - Towards Industrialisation
TCIOceania15 WelfareTech - Towards Industrialisation
TCI Network
 
Medicines optimisation: sharing best practices
Medicines optimisation: sharing best practicesMedicines optimisation: sharing best practices
Medicines optimisation: sharing best practices
AALForum
 
ECO 13: Knowledge Transfer Network Overview
ECO 13: Knowledge Transfer Network OverviewECO 13: Knowledge Transfer Network Overview
ECO 13: Knowledge Transfer Network Overview
Innovation Agency
 
Innovate UK Future Worlds Event - Living World – Mark Kelly
Innovate UK Future Worlds Event - Living World – Mark KellyInnovate UK Future Worlds Event - Living World – Mark Kelly
Innovate UK Future Worlds Event - Living World – Mark Kelly
Invest Northern Ireland
 
Andy Cairns - Access to Funding Liverpool SME Workshop
Andy Cairns - Access to Funding Liverpool SME WorkshopAndy Cairns - Access to Funding Liverpool SME Workshop
Andy Cairns - Access to Funding Liverpool SME Workshop
Innovation Agency
 
Innovation in medical device and diagnostic industry at India Leadership Conc...
Innovation in medical device and diagnostic industry at India Leadership Conc...Innovation in medical device and diagnostic industry at India Leadership Conc...
Innovation in medical device and diagnostic industry at India Leadership Conc...
Indian Affairs
 
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Cell and Gene Therapy Catapult
 
Indian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdf
Indian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdfIndian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdf
Indian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdf
Tom Aspinall
 
Stratified Medicine - Setting the Scene
Stratified Medicine - Setting the SceneStratified Medicine - Setting the Scene
Stratified Medicine - Setting the SceneSpace IDEAS Hub
 
Dr. Anne Blackwood, Chief Executive, Health Enterprise East
Dr. Anne Blackwood, Chief Executive, Health Enterprise EastDr. Anne Blackwood, Chief Executive, Health Enterprise East
Dr. Anne Blackwood, Chief Executive, Health Enterprise East
IMSTA
 
Nw biotech fundamentals day 2 session 5 summary and wrap up
Nw biotech fundamentals day 2 session 5   summary and wrap upNw biotech fundamentals day 2 session 5   summary and wrap up
Nw biotech fundamentals day 2 session 5 summary and wrap up
Nicholas Weston Lawyers
 
BPS "Corporate Startup Engagement"_Philips
BPS "Corporate Startup Engagement"_PhilipsBPS "Corporate Startup Engagement"_Philips
BPS "Corporate Startup Engagement"_Philips
Corporate Startup Summit
 

Similar to The IDA Ireland strategy for the pharmaceutical industy in Ireland (20)

Innovate UK - Chris Geary
Innovate UK - Chris GearyInnovate UK - Chris Geary
Innovate UK - Chris Geary
 
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
Marcel de Pender, Slimmer Leven 2010 “Regional Strategy in The Province Noord...
 
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh
"Where Agri Meets Tech,  Driving Research to Market" Ultan O’Raghallaigh "Where Agri Meets Tech,  Driving Research to Market" Ultan O’Raghallaigh
"Where Agri Meets Tech, Driving Research to Market" Ultan O’Raghallaigh
 
The Cell Therapy Catapult: Keith Thompson CEO January 2013
The Cell Therapy Catapult: Keith Thompson CEO January 2013The Cell Therapy Catapult: Keith Thompson CEO January 2013
The Cell Therapy Catapult: Keith Thompson CEO January 2013
 
Presentation - Funding for Innovation in Life & Health Sciences
Presentation - Funding for Innovation in Life & Health SciencesPresentation - Funding for Innovation in Life & Health Sciences
Presentation - Funding for Innovation in Life & Health Sciences
 
EIC slides april 23 20203.pptx
EIC slides april 23 20203.pptxEIC slides april 23 20203.pptx
EIC slides april 23 20203.pptx
 
Fra olje til helseteknologi
Fra olje til helseteknologiFra olje til helseteknologi
Fra olje til helseteknologi
 
Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)Finn Medi Presentation study visit (Life Sciences Sector)
Finn Medi Presentation study visit (Life Sciences Sector)
 
TCIOceania15 WelfareTech - Towards Industrialisation
TCIOceania15 WelfareTech - Towards IndustrialisationTCIOceania15 WelfareTech - Towards Industrialisation
TCIOceania15 WelfareTech - Towards Industrialisation
 
Medicines optimisation: sharing best practices
Medicines optimisation: sharing best practicesMedicines optimisation: sharing best practices
Medicines optimisation: sharing best practices
 
ECO 13: Knowledge Transfer Network Overview
ECO 13: Knowledge Transfer Network OverviewECO 13: Knowledge Transfer Network Overview
ECO 13: Knowledge Transfer Network Overview
 
Innovate UK Future Worlds Event - Living World – Mark Kelly
Innovate UK Future Worlds Event - Living World – Mark KellyInnovate UK Future Worlds Event - Living World – Mark Kelly
Innovate UK Future Worlds Event - Living World – Mark Kelly
 
Andy Cairns - Access to Funding Liverpool SME Workshop
Andy Cairns - Access to Funding Liverpool SME WorkshopAndy Cairns - Access to Funding Liverpool SME Workshop
Andy Cairns - Access to Funding Liverpool SME Workshop
 
Innovation in medical device and diagnostic industry at India Leadership Conc...
Innovation in medical device and diagnostic industry at India Leadership Conc...Innovation in medical device and diagnostic industry at India Leadership Conc...
Innovation in medical device and diagnostic industry at India Leadership Conc...
 
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
Autologous and Allogeneic Cell Therapy Industrialisation – Overcoming Clinica...
 
Indian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdf
Indian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdfIndian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdf
Indian-Pharmaceutical-Industry-Overview-and-Way-Forward.pdf
 
Stratified Medicine - Setting the Scene
Stratified Medicine - Setting the SceneStratified Medicine - Setting the Scene
Stratified Medicine - Setting the Scene
 
Dr. Anne Blackwood, Chief Executive, Health Enterprise East
Dr. Anne Blackwood, Chief Executive, Health Enterprise EastDr. Anne Blackwood, Chief Executive, Health Enterprise East
Dr. Anne Blackwood, Chief Executive, Health Enterprise East
 
Nw biotech fundamentals day 2 session 5 summary and wrap up
Nw biotech fundamentals day 2 session 5   summary and wrap upNw biotech fundamentals day 2 session 5   summary and wrap up
Nw biotech fundamentals day 2 session 5 summary and wrap up
 
BPS "Corporate Startup Engagement"_Philips
BPS "Corporate Startup Engagement"_PhilipsBPS "Corporate Startup Engagement"_Philips
BPS "Corporate Startup Engagement"_Philips
 

More from Irish Pharmaceutical Healthcare Association (IPHA)

The Healthcare Funding and Delivery Challenge in Ireland
The Healthcare Funding and Delivery Challenge in IrelandThe Healthcare Funding and Delivery Challenge in Ireland
The Healthcare Funding and Delivery Challenge in Ireland
Irish Pharmaceutical Healthcare Association (IPHA)
 
Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...
Irish Pharmaceutical Healthcare Association (IPHA)
 
The Value of Medicines and Vaccines to Irish patients and the Irish economy
The Value of Medicines and Vaccines to Irish patients and the Irish economyThe Value of Medicines and Vaccines to Irish patients and the Irish economy
The Value of Medicines and Vaccines to Irish patients and the Irish economy
Irish Pharmaceutical Healthcare Association (IPHA)
 
How to ensure the best utilisation of healthcare resources in Ireland - the e...
How to ensure the best utilisation of healthcare resources in Ireland - the e...How to ensure the best utilisation of healthcare resources in Ireland - the e...
How to ensure the best utilisation of healthcare resources in Ireland - the e...
Irish Pharmaceutical Healthcare Association (IPHA)
 
The role of Health Technology Assessment and current developments in Ireland
The role of Health Technology Assessment and current developments in IrelandThe role of Health Technology Assessment and current developments in Ireland
The role of Health Technology Assessment and current developments in Ireland
Irish Pharmaceutical Healthcare Association (IPHA)
 
The Development of National Programmes of Care in Ireland
The Development of National Programmes of Care in IrelandThe Development of National Programmes of Care in Ireland
The Development of National Programmes of Care in Ireland
Irish Pharmaceutical Healthcare Association (IPHA)
 
The role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in IrelandThe role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in Ireland
Irish Pharmaceutical Healthcare Association (IPHA)
 
Pharmaceutical Healthcare Facts and Figures 2010
Pharmaceutical Healthcare Facts and Figures 2010Pharmaceutical Healthcare Facts and Figures 2010
Pharmaceutical Healthcare Facts and Figures 2010
Irish Pharmaceutical Healthcare Association (IPHA)
 
Consumer Driven Healthcare
Consumer Driven HealthcareConsumer Driven Healthcare
Mens use of health services; a no man's land?
Mens use of health services; a no man's land?Mens use of health services; a no man's land?
Mens use of health services; a no man's land?
Irish Pharmaceutical Healthcare Association (IPHA)
 
Projected impact of demographic change on the demand for pharmaceuticals in I...
Projected impact of demographic change on the demand for pharmaceuticals in I...Projected impact of demographic change on the demand for pharmaceuticals in I...
Projected impact of demographic change on the demand for pharmaceuticals in I...
Irish Pharmaceutical Healthcare Association (IPHA)
 
Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery
Irish Pharmaceutical Healthcare Association (IPHA)
 
The health challenges facing Irish society
The health challenges facing Irish societyThe health challenges facing Irish society
The health challenges facing Irish society
Irish Pharmaceutical Healthcare Association (IPHA)
 
The challenges facing the pharmaceutical industry through to 2020
The challenges facing the pharmaceutical industry through to 2020The challenges facing the pharmaceutical industry through to 2020
The challenges facing the pharmaceutical industry through to 2020
Irish Pharmaceutical Healthcare Association (IPHA)
 
IPHA Healthcare Facts And Figures 2009
IPHA Healthcare Facts And Figures 2009IPHA Healthcare Facts And Figures 2009
IPHA Healthcare Facts And Figures 2009
Irish Pharmaceutical Healthcare Association (IPHA)
 
Driven By Health: Pharmaceutical Industry Corporate Responsibility in Ireland
Driven By Health: Pharmaceutical Industry Corporate Responsibility in IrelandDriven By Health: Pharmaceutical Industry Corporate Responsibility in Ireland
Driven By Health: Pharmaceutical Industry Corporate Responsibility in Ireland
Irish Pharmaceutical Healthcare Association (IPHA)
 

More from Irish Pharmaceutical Healthcare Association (IPHA) (18)

Session 2 Panel Discussion
Session 2 Panel DiscussionSession 2 Panel Discussion
Session 2 Panel Discussion
 
The Healthcare Funding and Delivery Challenge in Ireland
The Healthcare Funding and Delivery Challenge in IrelandThe Healthcare Funding and Delivery Challenge in Ireland
The Healthcare Funding and Delivery Challenge in Ireland
 
Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...
 
The Value of Medicines and Vaccines to Irish patients and the Irish economy
The Value of Medicines and Vaccines to Irish patients and the Irish economyThe Value of Medicines and Vaccines to Irish patients and the Irish economy
The Value of Medicines and Vaccines to Irish patients and the Irish economy
 
How to ensure the best utilisation of healthcare resources in Ireland - the e...
How to ensure the best utilisation of healthcare resources in Ireland - the e...How to ensure the best utilisation of healthcare resources in Ireland - the e...
How to ensure the best utilisation of healthcare resources in Ireland - the e...
 
The role of Health Technology Assessment and current developments in Ireland
The role of Health Technology Assessment and current developments in IrelandThe role of Health Technology Assessment and current developments in Ireland
The role of Health Technology Assessment and current developments in Ireland
 
The Development of National Programmes of Care in Ireland
The Development of National Programmes of Care in IrelandThe Development of National Programmes of Care in Ireland
The Development of National Programmes of Care in Ireland
 
The role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in IrelandThe role of clinical research in securing the future of the industry in Ireland
The role of clinical research in securing the future of the industry in Ireland
 
The Development of a New Medicine
The Development of a New MedicineThe Development of a New Medicine
The Development of a New Medicine
 
Pharmaceutical Healthcare Facts and Figures 2010
Pharmaceutical Healthcare Facts and Figures 2010Pharmaceutical Healthcare Facts and Figures 2010
Pharmaceutical Healthcare Facts and Figures 2010
 
Consumer Driven Healthcare
Consumer Driven HealthcareConsumer Driven Healthcare
Consumer Driven Healthcare
 
Mens use of health services; a no man's land?
Mens use of health services; a no man's land?Mens use of health services; a no man's land?
Mens use of health services; a no man's land?
 
Projected impact of demographic change on the demand for pharmaceuticals in I...
Projected impact of demographic change on the demand for pharmaceuticals in I...Projected impact of demographic change on the demand for pharmaceuticals in I...
Projected impact of demographic change on the demand for pharmaceuticals in I...
 
Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery
 
The health challenges facing Irish society
The health challenges facing Irish societyThe health challenges facing Irish society
The health challenges facing Irish society
 
The challenges facing the pharmaceutical industry through to 2020
The challenges facing the pharmaceutical industry through to 2020The challenges facing the pharmaceutical industry through to 2020
The challenges facing the pharmaceutical industry through to 2020
 
IPHA Healthcare Facts And Figures 2009
IPHA Healthcare Facts And Figures 2009IPHA Healthcare Facts And Figures 2009
IPHA Healthcare Facts And Figures 2009
 
Driven By Health: Pharmaceutical Industry Corporate Responsibility in Ireland
Driven By Health: Pharmaceutical Industry Corporate Responsibility in IrelandDriven By Health: Pharmaceutical Industry Corporate Responsibility in Ireland
Driven By Health: Pharmaceutical Industry Corporate Responsibility in Ireland
 

Recently uploaded

The key differences between the MDR and IVDR in the EU
The key differences between the MDR and IVDR in the EUThe key differences between the MDR and IVDR in the EU
The key differences between the MDR and IVDR in the EU
Allensmith572606
 
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdfMeas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
dylandmeas
 
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-indiafalcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
Falcon Invoice Discounting
 
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
BBPMedia1
 
Cracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptxCracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptx
Workforce Group
 
Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111
zoyaansari11365
 
Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)
Lviv Startup Club
 
Business Valuation Principles for Entrepreneurs
Business Valuation Principles for EntrepreneursBusiness Valuation Principles for Entrepreneurs
Business Valuation Principles for Entrepreneurs
Ben Wann
 
Affordable Stationery Printing Services in Jaipur | Navpack n Print
Affordable Stationery Printing Services in Jaipur | Navpack n PrintAffordable Stationery Printing Services in Jaipur | Navpack n Print
Affordable Stationery Printing Services in Jaipur | Navpack n Print
Navpack & Print
 
amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05
marketing317746
 
Sustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & EconomySustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & Economy
Operational Excellence Consulting
 
CADAVER AS OUR FIRST TEACHER anatomt in your.pptx
CADAVER AS OUR FIRST TEACHER anatomt in your.pptxCADAVER AS OUR FIRST TEACHER anatomt in your.pptx
CADAVER AS OUR FIRST TEACHER anatomt in your.pptx
fakeloginn69
 
What is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdfWhat is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdf
seoforlegalpillers
 
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdfikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
agatadrynko
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
Nicola Wreford-Howard
 
Search Disrupted Google’s Leaked Documents Rock the SEO World.pdf
Search Disrupted Google’s Leaked Documents Rock the SEO World.pdfSearch Disrupted Google’s Leaked Documents Rock the SEO World.pdf
Search Disrupted Google’s Leaked Documents Rock the SEO World.pdf
Arihant Webtech Pvt. Ltd
 
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
BBPMedia1
 
Creative Web Design Company in Singapore
Creative Web Design Company in SingaporeCreative Web Design Company in Singapore
Creative Web Design Company in Singapore
techboxsqauremedia
 
-- June 2024 is National Volunteer Month --
-- June 2024 is National Volunteer Month ---- June 2024 is National Volunteer Month --
-- June 2024 is National Volunteer Month --
NZSG
 
FINAL PRESENTATION.pptx12143241324134134
FINAL PRESENTATION.pptx12143241324134134FINAL PRESENTATION.pptx12143241324134134
FINAL PRESENTATION.pptx12143241324134134
LR1709MUSIC
 

Recently uploaded (20)

The key differences between the MDR and IVDR in the EU
The key differences between the MDR and IVDR in the EUThe key differences between the MDR and IVDR in the EU
The key differences between the MDR and IVDR in the EU
 
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdfMeas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
Meas_Dylan_DMBS_PB1_2024-05XX_Revised.pdf
 
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-indiafalcon-invoice-discounting-a-premier-platform-for-investors-in-india
falcon-invoice-discounting-a-premier-platform-for-investors-in-india
 
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...
 
Cracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptxCracking the Workplace Discipline Code Main.pptx
Cracking the Workplace Discipline Code Main.pptx
 
Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111Introduction to Amazon company 111111111111
Introduction to Amazon company 111111111111
 
Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)Maksym Vyshnivetskyi: PMO Quality Management (UA)
Maksym Vyshnivetskyi: PMO Quality Management (UA)
 
Business Valuation Principles for Entrepreneurs
Business Valuation Principles for EntrepreneursBusiness Valuation Principles for Entrepreneurs
Business Valuation Principles for Entrepreneurs
 
Affordable Stationery Printing Services in Jaipur | Navpack n Print
Affordable Stationery Printing Services in Jaipur | Navpack n PrintAffordable Stationery Printing Services in Jaipur | Navpack n Print
Affordable Stationery Printing Services in Jaipur | Navpack n Print
 
amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05amptalk_RecruitingDeck_english_2024.06.05
amptalk_RecruitingDeck_english_2024.06.05
 
Sustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & EconomySustainability: Balancing the Environment, Equity & Economy
Sustainability: Balancing the Environment, Equity & Economy
 
CADAVER AS OUR FIRST TEACHER anatomt in your.pptx
CADAVER AS OUR FIRST TEACHER anatomt in your.pptxCADAVER AS OUR FIRST TEACHER anatomt in your.pptx
CADAVER AS OUR FIRST TEACHER anatomt in your.pptx
 
What is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdfWhat is the TDS Return Filing Due Date for FY 2024-25.pdf
What is the TDS Return Filing Due Date for FY 2024-25.pdf
 
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdfikea_woodgreen_petscharity_cat-alogue_digital.pdf
ikea_woodgreen_petscharity_cat-alogue_digital.pdf
 
Exploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social DreamingExploring Patterns of Connection with Social Dreaming
Exploring Patterns of Connection with Social Dreaming
 
Search Disrupted Google’s Leaked Documents Rock the SEO World.pdf
Search Disrupted Google’s Leaked Documents Rock the SEO World.pdfSearch Disrupted Google’s Leaked Documents Rock the SEO World.pdf
Search Disrupted Google’s Leaked Documents Rock the SEO World.pdf
 
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...
 
Creative Web Design Company in Singapore
Creative Web Design Company in SingaporeCreative Web Design Company in Singapore
Creative Web Design Company in Singapore
 
-- June 2024 is National Volunteer Month --
-- June 2024 is National Volunteer Month ---- June 2024 is National Volunteer Month --
-- June 2024 is National Volunteer Month --
 
FINAL PRESENTATION.pptx12143241324134134
FINAL PRESENTATION.pptx12143241324134134FINAL PRESENTATION.pptx12143241324134134
FINAL PRESENTATION.pptx12143241324134134
 

The IDA Ireland strategy for the pharmaceutical industy in Ireland

  • 1. Irish Pharmaceutical Healthcare Association (IPHA) Annual Meeting Barry O’Leary November 25th 2010
  • 2. Current Impact of FDI gh KEY FDI IMPACTS ON THE IRISH ECONOMY - €110 BN Exports - 240,000 Jobs in Total - 55% of Corporation Tax - €19 BN Expenditure - €7 BN Payroll - 73% of Business RD&I expenditure WORLD LEADERS CHOOSE IRELAND - 8 of the top 10 in ICT - 8 of the top 10 in Pharmaceuticals - 15 of the top 25 in Medical Devices - More than 50% of the world’s leading Financial Services firms
  • 3. • Global Services • High-end Manufacturing • Research, Development & Innovation Business Model Focus Sectors • Life Sciences - Pharma/Biopharma & - Medical Devices • Information & Communications Technology • Financial Services • Content Industry, Consumer & Business Services • Diversified Industries and Engineering • CleanTech IDA Focus
  • 4. FDI 2010 – Recent Wins Existing Clients
  • 5. FDI Recent Wins – New Clients
  • 6. Ireland – major Life Sciences Hub Biopharma Med Tech Healthcare Services • 8 0f the top 10 Pharma • 8 of top 10 and 15 of top 25 Medical Technologies • 44,000 jobs • Exports €51 Bn p.a. • Numerous sub-suppiier and service providers
  • 7. Recent Lifesciences FDI Investments Investing €220m in a new fill finish vaccines facility (170 jobs) Carlow. EMEA Service Centre in Dublin (150 Jobs). EMEA Shared Services for 100 people, Cork. Biologics, €400m investment. Investing over €160m in R&D in Galway, Cork and Clonmel Global manufacturing and development, 204 people, Dundalk 100 person manufacturing expansion in Co. Galway 250 person manufacturing expansion in Ballina €30m investment in bio-analytical / chemistry services, 250 Jobs in Athlone Expansion of €130m and 170 new jobs European Shared Services Centre in Cork - 30 jobs European Services Centre in Dublin, creating more than 200 job. €50 million new manufacturing investment, creating 250 jobs in Clare
  • 8. Global Lifesciences Industry Drivers/Challenges Pharma • Patent cliff – increased generics • Pipeline Challenge • Restructuring to accommodate new reality – M&A, cost reduction • Increasing Regulatory hurdles and costs • US Healthcare reform – biosimilars pathway • Biologics • Rise of Asia • Ageing population • Healthcare reform tax • 510K regulatory pathway changes USA • Convergence – clear coupling of devices and tech. • Asian market growing strongly
  • 9. 9 Ageing population 20%+ of population will be over 65 in developed markets by 2025 Emerging markets Pharma market expected to double by 2015 Unmet needs Oncology, immunology, antiviral HIV, stroke, Alzheimer's, obesity, thrombosis, HCV New technologies e.g., Predictive technologies, such as biomarkers, in silico models Increasing demand Demand for healthcare to continue to grow Broader offer 1. Source : IMS Market prognosis Copyright©2010byTheBostonConsultingGroup,Inc.Allrightsreserved.
  • 10. Evolution of Pharma Bio • Single Platform Technology • API manufacturing • Q&A labs • Sophisticated manufacturing • Liquids • Tabletting • Creams • Patches • Molecular diagnostics • Reference Global Sites • Biopharma • Shared services - Supply chain, Regulatory, Finance • Commodity medicines • Self-Dx, Self Treat • Nutraceuticals • Convergent technologies • Connected Health • Personalised Medicine • Combination medical products • Medical Services 1980s 1990s 2000s 2020
  • 11. 11 Horizon 2020 - Ongoing Evolution of Pharma Bio 2010-2015- Capturing and Delivering marketplace opportunites • Integrating disease with lifestyle management • Leveraging expertise in nutraceuticals, point of care assays • Advancing molecular diagnostics and targetted therapies • Utilising genetic testing & biomarkers in advanced clinical trials • Developing convergent medical products • Rise of bioinfomatics, population health strategies Now - Building and Developing the sector • Winning new biopharma investments • Leveraging NiBRT to advance Biopharma Industry • Enhancing Ireland’s small molecule Value Proposition • Support vaccine development, generic reformulation, improved drug delivery • Expanding mandates of top 30 companies “start earlier-finish later” • Supporting new starts in packaging, tabletting, labelling, supply chain • Expanding footprints into shared services, commercialisation, clinical trials
  • 12. 12 Horizon 2020 - Ongoing Evolution of Pharma Bio 2020 Foresight • Convergent medical management – drug & dynamic device • Regenerative Health platforms in ageing, organ, joint replacement • Connected Health platforms integrating e-health • Cancer vaccines, targeted personal therapies • Advancing silver care, aged care, focus on mental wellness • Tailored health insurance per decade of life • Development of “polypill” • Integrated digital medical record and decision support • Remote monitoring and treatment at home • New bioactive materials and molecules from marine ecosystem
  • 13. Ireland : A Proven Location for Lifesciences Service Activities
  • 14. Initiatives to protect and grow Industry • Transformation – – Technology uplift, – Skills uplift – Process development – Product Development – Energy Efficiency – Operational excellence • Strategic Sites and CMO • NIBRT for Bio • National Commercialisation centre for medical devices • National competence centre for small molecule production • International healthcare services centre • Healthcare Innovation hub with HSE • Research and Development Agenda
  • 15. • TV Ads • Live TV Interviews • Online Media • Print Media • Airport Posters • Press Interviews • Web Optimisation Integrated Communications Campaign
  • 16.
  • 17. Professor Luke O’Neill – Trinity College Dublin
  • 18.
  • 19.
  • 20. IDA TV Ad – 30 Secs